Influence of Apolipoproteins on the Association Between Lipids and Insulin Sensitivity: A cross-sectional analysis of the RISC Study

Apolipoprotein CIII Links Dyslipidemia with Atherosclerosis

(2011) Akio Kawakami et al.   Journal of Atherosclerosis and Thrombosis

Impact of HDL on adipose tissue metabolism and adiponectin expression

(2010) Sophie Van Linthout et al.   ATHEROSCLEROSIS

Apolipoprotein A-I possesses an anti-obesity effect associated with increase of energy expenditure and up-regulation of UCP1 in brown fat

(2010) Xiangbo Ruan et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Increased apolipoprotein E level and reduced high-density lipoprotein mean particle size associate with low high-density lipoprotein cholesterol and features of metabolic syndrome

(2010) Sanni Söderlund et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Apolipoprotein C3 Gene Variants in Nonalcoholic Fatty Liver Disease

(2010) Kitt Falk Petersen et al.   NEW ENGLAND JOURNAL OF MEDICINE

High-Density Lipoprotein Modulates Glucose Metabolism in Patients With Type 2 Diabetes Mellitus

(2009) Brian G. Drew et al.   CIRCULATION

Plasma Apolipoprotein CI and CIII Levels Are Associated With Increased Plasma Triglyceride Levels and Decreased Fat Mass in Men With the Metabolic Syndrome

(2008) R. L.M. van der Ham et al.   DIABETES CARE

Structure and Dynamics of Human Apolipoprotein CIII

(2008) Chinthaka Saneth Gangabadage et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

L-4F treatment reduces adiposity, increases adiponectin levels, and improves insulin sensitivity in obese mice

(2008) Stephen J. Peterson et al.   JOURNAL OF LIPID RESEARCH